NewLimit

NewLimit appears in Bryan Johnson: I Just Took the Most Powerful Dose of DMT in the World… Here’s What It Was Like as a Bryan Johnson investment connected to cellular reprogramming. The episode uses the company to discuss computational discovery around Yamanaka-factor-like interventions and the need to control dosing tightly enough to avoid cancer or other severe failures.

For the wiki, NewLimit sits between Life Reprogramming Vision and Cellular Reprogramming Control Problem. It is not presented as proof that rejuvenation is solved; it is a company example inside the broader claim that longevity biology may become programmable only if control, safety, and validation improve.

Connections

• Bryan Johnson - investor and source guest.
• Cellular Reprogramming Control Problem - risk frame attached to Yamanaka-factor dosing.
• Life Reprogramming Vision, Patient-Derived Organoids, and Clinical Development Capability - adjacent validation and biology-programming concepts.